NIH Guide to Grants and Contracts

The NIH Guide for Grants and Contracts is our official publication for NIH grant policies, guidelines and funding opportunities. We publish daily, and issue a table of contents weekly. Learn more about the NIH Guide and subscribe today!

The old advanced search is still avaliable.

New Features:

  • Tabular view - You can now view the search results in table format.
  • Export to excel - Search results can now be exported to excel for reporting purposes.

Results: 26 to 42 of 42

Display Results as:

Title FOA Number Organization Released Expires Activity Code
Revision Applications for Mechanisms of Drug Resistance (R01 Clinical Trials Not Allowed)  RFA-CA-19-049  NCI  09-05-2019  06-24-2021  R01 
Revision Applications for Mechanisms of Drug Resistance (U01 Clinical Trials Not Allowed)  RFA-CA-19-050  NCI  09-05-2019  06-24-2021  U01 
Revision Applications for Mechanisms of Drug Resistance (P01 Clinical Trials Not Allowed)  RFA-CA-19-052  NCI  09-05-2019  06-24-2021  P01 
Revision Applications for Mechanisms of Drug Resistance (P50 Clinical Trials Not Allowed)  RFA-CA-19-053  NCI  09-05-2019  06-24-2021  P50 
Participant Engagement and Cancer Genome Sequencing (PE-CGS): Research Centers (U2C Clinical Trial Optional)  RFA-CA-19-045  NCI  07-30-2019  07-31-2020  U2C 
Participant Engagement and Cancer Genome Sequencing (PE-CGS): Coordinating Center (U24 Clinical Trial Not Allowed)  RFA-CA-19-046  NCI  07-30-2019  07-31-2020  U24 
Secondary Analyses of Existing Datasets of Tobacco Use and Health (R21 Clinical Trial Not Allowed)  RFA-OD-19-022  ODP  07-08-2019  03-09-2021  R21 
Maximizing the Scientific Value of Existing Biospecimen Collections: Scientific Opportunities for Exploratory Research (R21 Clinical Trial Not Allowed)  RFA-OD-19-021  ODP  07-08-2019  03-09-2021  R21 
Feasibility and Planning Studies for Development of Specialized Programs of Research Excellence (SPOREs) to Investigate Cancer Health Disparities (P20 Clinical Trial Optional)  RFA-CA-19-034  NCI  03-13-2019  10-19-2020  P20 
Provocative Questions (PQs) in Cancer with an Underlying HIV Infection (R01 Clinical Trial Optional)  RFA-CA-19-032  NCI  01-24-2019  08-04-2020  R01 
HEAL Initiative: Translational Devices to Treat Pain (UG3/UH3 Clinical Trial Optional)  RFA-NS-19-016  NINDS  12-10-2018  02-23-2021  UG3/UH3 
HEAL Initiative: Clinical Devices to Treat Pain (UH3 Clinical Trial Optional)  RFA-NS-19-018  NINDS  12-10-2018  02-23-2021  UH3 
HEAL Initiative: Translational Devices to Treat Pain (U44 Clinical Trial Optional)  RFA-NS-19-017  NINDS  12-10-2018  02-23-2021  U44 
HEAL Initiative: Translational Development of Devices to Treat Pain (U18 Clinical Trial Not Allowed)  RFA-EB-18-003  NIBIB  12-10-2018  02-23-2021  U18 
Analytical and/or Clinical Validation of a Candidate Biomarker for Pain (R61/R33 Clinical Trial Optional)  RFA-NS-18-046  NINDS  09-19-2018  03-13-2020  R61/R33 
Discovery of Biomarkers, Biomarker Signatures, and Endpoints for Pain (R61/R33 Clinical Trial Optional)  RFA-NS-18-041  NINDS  08-02-2018  03-13-2020  R61/R33 
Stimulating Access to Research in Residency (StARR) (R38)  RFA-HL-18-023  NHLBI  08-23-2017  05-13-2020  R38 

Current Search

Clear All Filters

Organization(s): NCI

Refine Your Results

Program Announcements (PAs)

Parent Announcments Only

Requests for Applications (RFAs)

Issuing Only

All Organizations

AHRQ

CDC

CSR

DHHS

DOJ

EPA

FDA

FIC

HRSA

NASA

NCATS

NCBDDD

NCCDPHP

NCCIH

NCEH

NCHSTP

NCI

NCID

NCIPC

NCMHD

NCPHI

NCRR

NEI

NHGRI

NHLBI

NIA

NIAAA

NIAID

NIAMS

NIBIB

NICHD

NIDA

NIDCD

NIDCR

NIDDK

NIEHS

NIGMS

NIH

NIMH

NIMHD

NINDS

NINR

NIOSH

NIP

NLM

OAR

OBSSR

OD

ODP

ODS

OPHR

OPPNET

ORD

ORI

ORIP

ORWH

OSC

RMOD

Roadmap

SAMHSA

*On or After
*On or After
(e.g. "K" for K01 or K02, K05, etc.)
Back to Top